Jew (AJ) individuals. The purpose of this study was to determine the origin, age, and population distribution of G197del, as well as to explore environmental and genetic effects on disease expression. Index cases from Israel ( ), South Africa ( ), Russia ( ), The Netherlands ( ), and the United States ( ) were n p 46 n p 24 n p 7 n p 1 n p 1 enlisted. All trace their ancestry to Lithuania. A highly conserved haplotype (D19S221:104-D19S865:208-D19S413: 74) was identified in G197del chromosomes, suggesting the occurrence of a common founder. When two methods were used for analysis of linkage disequilibrium (LD) between flanking polymorphic markers and the disease locus and for the study of the decay of LD over time, the estimated age of the deletion was found to be 20 ‫ע‬ 7 generations (the 95% confidence interval is 15-26 generations), so that the most recent common ancestor of the mutation-bearing chromosomes would date to the 14th century. This corresponds with the founding of the Jewish community of Lithuania (1338 A.D.), as well as with the great demographic expansion of AJ individuals in eastern Europe, which followed this settlement. The penetrance of mutation-linked severe hypercholesterolemia is high (94% of heterozygotes have a baseline concentration of LDL cholesterol (LDL-C) that is 1160 mg/dl), and no significant differences in the mean baseline lipid level of G197del carriers from different countries were found. Polymorphisms of apolipoprotein E and of scavenger-receptor class B type I were observed to have minor effects on the plasma lipid profile. With respect to determinative genetic influences on the biochemical phenotype, there is no evidence that could support the possibility of a selective evolutionary metabolic advantage. Therefore, the founder effect in a rapidly expanding population from a limited number of families remains a simple, parsimonious hypothesis explaining the spread of G197del-LDLR-linked FH in AJ individuals.
Introduction
Familial hypercholesterolemia (FH; also known as "hyperlipoproteinemia type IIa" [MIM 143890] ) is an autosomal codominant disorder characterized by elevated plasma levels of LDL cholesterol (LDL-C), tendinous xanthomas, corneal arcus, and premature atherosclerotic coronary artery disease. FH results from mutations at the LDL receptor (LDLR) gene, which lies on the short arm of chromosome 19 (at 19p13.1-p13.3 [Couture et al. 1999] ). LDLR consists of a 160-kD transmembrane glycoprotein, ubiquitously distributed and involved in the receptor-mediated endocytosis of LDL particles from plasma . LDLR gene spans 45 kb and contains 18 exons encoding the six functional domains of the mature protein (Sü dhof et al. 1985) . A reduction of LDLR activity leads to diminished catabolism of LDL-C, resulting in elevated plasma levels of cholesterol.
FH is one of the most common inherited metabolic diseases, with a worldwide frequency of у1/500 for heterozygotes and 1/1,000,000 for homozygotes (Gold-stein et al. 1995) . More than 680 LDLR mutations have been identified (Varret et al. 1998 [LDLR Database]; Heath et al. 2001 [The Low Density Lipoprotein Receptor (LDLR) Gene in Familial Hypercholesterolemia]). In relatively isolated populations-including the French Canadians in northeastern Quebec (Moorjani et al. 1989; Leitersdorf et al. 1990 ), Afrikaners in South Africa (Steyn et al. 1989; Kotze et al. 1991) , Ashkenazi Jew (AJ) individuals (Seftel et al. 1989; Meiner et al. 1991) , Druze (Landsberger et al. 1992) , Christian Lebanese (Lehrman et al. 1987) , Finns Koivisto et al. 1992) , and Tunisians (Slimane et al. 1993 )-there is an increased prevalence of FH, which reaches its height in AJ individuals (in whom the frequency is 1 heterozygote per 67-69 individual [Seftel et al. 1989] ). In these populations, a small number of LDLR mutations predominate, which either were introduced at a founder time or appeared in more-recent generations.
Wide interindividual variability in plasma lipid profile (PLP) has been observed in FH heterozygotes, and this feature is only partly due to mutational heterogeneity at the LDLR locus (Moorjani et al. 1993; Bertolini et al. 2000) . Genetic and/or environmental factors are suspected to influence the pathways of lipoprotein metabolism in patients with FH, to an extent and by a mechanism that remain to be ascertained.
The most prevalent FH-causing LDLR mutation in Jews from eastern Europe (mainly Lithuania) now residing in Israel is a 3-bp deletion in exon 4 of the LDLR gene (652delGGT) (Meiner et al. 1991) . The mutation results in the deletion of Gly 197 (G197del) in a highly conserved cysteine-rich repeat of the ligand-binding domain of the receptor. The defective protein fails to be transported to the Golgi complex at a normal rate (LDLR mutational functional class IIb ), most likely because of improper folding. G197del was originally described in a patient homozygous for FH who was from the United States . It was also found in eight South African Jews (Meiner et al. 1991) , six unrelated Jewish families from the United Kingdom (Gudnason et al. 1993) , one German (Geisel et al. 1995) , and seven Jews with FH who were from St. Petersburg (Mandelshtam et al. 1998) . In this article, we address the question as to whether this mutation had a single origin and, if so, when and where the mutational event occurred. To this end, we used the observed distribution of allelic variants of three flanking short tandem-repeat (STR) markers (D19S221, D19S865, and D19S413) on mutant and control chromosomes, to estimate the age of the mutation by linkage disequilibrium (LD) analysis and by modeling LD's decay over time.
Among disease in AJ individuals, FH has received scarce attention from population geneticists. This is due to its allelic heterogeneity at the LDLR locus and to the consequent difficulty in enlisting a number of genetically homogeneous independent cases (to date, eight different mutations have been detected in families with FH that are of AJ origin [Varret et al. 1998: LDLR Database) . However, the dominant inheritance pattern of FH, an infrequent phenomenon among disorders in AJ individuals, supplies a novel opportunity to address the intriguing issue of why such an array of genetic disease has a high frequency in the AJ population. Provided that their penetrance is high even in heterozygotes and that modifying genetic factors do not influence, in a considerable way, the expressed phenotypes, dominant mutations are exposed to direct selection uniformly within and among populations, and the hypothesis of carrier advantage does not apply in this case. In an attempt to exclude major interference that polymorphisms known to affect cholesterol metabolism in other circumstances might have on the G197del-linked biochemical phenotype, the influences that common genotypes of apolipoprotein E (ApoE; Hagberg et al. 2000) and of scavenger receptor class B type I (SR-BI; Iwaki et al. 1999 ) have on the baseline PLP of index cases from different countries were investigated. The results support the eligibility of this FH founder mutation for a straightforward model for studying the genetic history (and the underlying mechanisms) that have yielded the spectrum of inherited disorders observed at remarkable frequency in the AJ population today.
Subjects, Material, and Methods

Families and Subjects
A total of 46 families from Israel, 24 families from South Africa, 7 families from Russia, 1 family from The Netherlands, and 1 family from United States were collected by an international cooperative effort aimed at comparing the FH phenotypic variance among geographic areas, to evaluate disease penetrance and the effects that environmental and modifying genetic factors have on the biochemical manifestations of the disorder. Written informed consent was obtained prior to the families' participation, under protocols approved by the local institutional review boards. Index cases (table 1) were patients with marked hypercholesterolemia and a documented history of FH in their families and were carriers of G197del in the LDLR gene (Meiner et al. 1991) . Information on the geographic location of current and ancestral settlements of families was obtained by asking for the birthplace of the proband and of his or her grandparents. Detailed interviews excluded cases from related families. Most, if not all, index cases are of AJ origin or of mixed AJ-non-AJ origin. Of the 46 patients residing in Israel, one (index case 430-002) belongs to an Iraqi Jewish family whose pedigree includes a marriage between one ancestor and an AJ women. Of the three nonwhite patients ("coloured" population) residing in South Africa, two are known to have AJ-mixed ancestry (Loubser et al. 1999 ). The case from The Netherlands is Christian, whereas the patient from the United States (Piscataway, NJ) is of AJ origin (Poland) and represents the only subject homozygous for the 197del LDLR mutation.
A cohort of 45 control AJ individuals from Israel, providing 90 normal independent chromosomes, was used for estimating the frequencies of alleles at marker loci. Control subjects included family members and unrelated individuals.
Biochemical Determinations
PLPs of the index cases are reported in table 1. Blood was collected in tubes containing EDTA, after an overnight fast and before any hypolipidemic drug or dietary treatment. By means of commercially available diagnostic kits, plasma total cholesterol (TC), triglycerides (TG), and LDL cholesterol (HDL-C) were analyzed in local laboratories, by standardized enzymatic methods, either directly (in the case of TC and TG) or in the supernatant after chemical precipitation of ApoB-containing lipoproteins (in the case of HDL-C). LDL-C was calculated by means of the Friedewald et al. (1972) formula.
Genotyping and Haplotyping
DNA was isolated from peripheral blood leukocytes, by standard procedures. Chromosomes were screened for the G197del LDLR mutation, by PCR amplification and heteroduplex analysis as described elsewhere (Meiner et al. 1991) . With one exception (the individual from Piscataway, NJ), all patients were heterozygous for the mutation. Three polymorphic markers (The Genome Database accession number; repeat, amplimer) were used for genotyping disease and normal chromosomes: D19S221 (188431; (CA) n , AFM224ye9), D19S865 (602894; (CA) n , AFMa107xc9), and D19S413 (199839; (CA) n , AFM292wd9). Fluorescently labeled primers (ABI-PRISM [F]dUTPs) for D19S221 and D19S865 were purchased from PE Applied Biosystems. PCR conditions were according to the manufacturer's protocols. Fluorescently labeled primers for D19S413 were 5 -GTTTATTTTAAATGCTCTTACCACA-3 (forward) and 5 -CCATCAACTCACCTACTTATCGT-3 (reverse). PCR was performed under the following condition: 95ЊC for 12 min; followed by 10 cycles of 94ЊC for 15 s, 55ЊC for 15 s, and 72ЊC for 30 s; 20 cycles of 89ЊC for 15 s, 55ЊC for 15 s, and 72ЊC for 30 s; and a final extension at 72ЊC for 10 min. The reaction mixture contained 1.2 ml of DNA (50 ng/ml), 1 ml each of the forward and reverse primers (10 pmol/ml), 2.8 ml of double-distilled water (DDW), and 9 ml of ABI-PRISM PCR premix solution. Allele sizes were determined on an ABI 310 semiautomated sequencer, by comparison with size standards (400 HD Rox GENESCAN software). Haplotype data were obtained either from informative pedigrees (via cosegregation of microsatellite alleles) or via homozygosity at marker loci.
ApoE Restriction Isotyping
Restriction isotyping (restriction-enzyme isoform genotyping) has been used for typing common ApoE alleles (e2-e4) by means of a modified version of the procedure described by Hixson and Vernier (1990) . The method relies on PCR amplification of ApoE gene sequences that encompass amino acid positions 112 and 158, followed by CfoI cleavage of amplified DNA and separation of the resulting digestion fragments by gel electrophoresis. The following primers were used: 5 -GAGAAGCT-TGCGGCGCAGGCCCGGCTGGGCGCG-3 (forward) and 5 -TGAAGCTTCGCTCGGCGCCCTCGCGGGC-CCGGG-3 (reverse). PCR was performed under the following conditions: 94ЊC for 5 min, followed by 30 cycles of 94ЊC for 1.5 min and 72ЊC for 3 min. The PCR mixture contained 23 ml of each dNTP (10 mM), 1.14 ml of dimethylsulfoxide, 190 ml of NH 4 SO 4 (1 M), 600 ml of Tris-HCl (1 M; pH 9), 160 ml of Tris-HCl (1 M; pH 8), 76 ml of MgCl 2 (1 M), 140 ml of DTT (1 M), 193 ml of BSA, 7.44 ml of DDW, 2 ml of DNA (50 ng/ ml), and 0.2 ml of Taq DNA polymerase (5 U/ml). After amplification, 1 ml of CfoI (10 U/ml; Boehringer-Mannheim) was added to 15 ml of PCR mixture, according the manufacturer's instructions. The restriction mixture was left for 3 h at 37ЊC, and the product was separated on 8% polyacrylamide gel and was visualized by ethidium bromide staining. The sizes of CfoI fragments were estimated by comparison with markers of known size.
Analysis of SR-BI Polymorphisms
SNP C/T at codon 350 in exon 8 of the gene encoding for the SR-BI was detected by HaeIII (Acton et al. 1999 ). The following primers were employed: 5 -CTTG-TTTCTCTCCCATCCTCACTTCCTCAAGGC-3 (forward) and 5 -CACCACCCCAGCCCACAGCAGC-3 (reverse). PCR conditions were 94ЊC for 5 min, followed by 30 cycles of 94ЊC for 1 min, 68ЊC for 1 min, and 75ЊC for 1 min. The reaction mixture contained 0.2 ml of a-[ 32 P]dCTP (5 Ci/ml), 1 ml of each dNTP (10 mM), 1 ml each of the forward and reverse primers (optical density 5), 0.2 ml of Taq DNA polymerase (5 U/ml), 2 ml of PCR buffer (Roche Diagnostics), and 13.6 ml of DDW. Digestion with HaeIII (Boehringer Mannheim) was performed at 37ЊC for 2 h, according to the manufacturers' instructions. The product (20 ml) was separated on 8% polyacrylamide gel and was visualized by overnight exposure to a film plate. The sizes of HaeIII fragments were estimated by comparison with markers of known size.
LD Analysis
Allele-frequency distributions in disease and control AJ chromosomes were compared by evaluating the difference in proportions (Daniel 1995) . The cohorts of mutation-bearing and normal chromosomes were considered as two independent random samples-of size n D and n N , respectively-that are drawn from two populations of dichotomous variables; then, the proportion of observations with the characteristics of interest in the two populations are p D and p N (the frequencies of a marker's allele on disease-mutation-bearing and normal chromosomes, respectively), and the distribution of the difference between sample proportions is approximately normal, with normal mean equal to p D Ϫ p N and with variance
when n D and n N are large. According to standard biometrics, n D and n N can be considered sufficiently large
, and n N (1Ϫp N ) are all 15 and the population proportions are not too close to 0 or 1. For the area under the curve of the standard normal distribution (one sided, since each allele was tested for evidence of increased frequency on mutation-bearing chromosomes), significance of the observed difference can be derived by the statistic . Under
these circumstances, it is also possible to compute a % interval for the estimated difference, 100(1 Ϫ a)
. Theoretically, in the event
that the constraint indicated above is not met (frequency р5), a correction should be introduced; however, conditions requiring the correction are also those that rec-ommend against the use of the corresponding alleles for LD analysis. Similarly, nonsymmetric variance should be used for proportions close to 0 or 1, and, again, these circumstances do not recommend the allele as a candidate for LD analysis. Consequently, whenever the sample of chromosomes is reasonably large, the general formula can be applied. Since more than one allele was tested at each marker locus, a Bonferroni correction was applied by multiplication of the nominal significance level (P) by the number of alleles tested. The measure of LD, d, between each marker locus and G197del was calculated, according to the method of Bengtsson and Thomson (1981) , as (p D Ϫp N )/(1Ϫp N ). Recently, Diaz et al. (2000) suggested that a confidence interval (CI) for d can be conveniently calculated under the assumption of independence for the sampled chromosomes. Since is a function
of the ratio of two independent random variables, the variance of d can be approximated by
where and
The sex-averaged v between each polymorphic marker and LDLR gene was obtained from Couture et al. (1999) . The v's between D19S221, D19S413, and the LDLR locus were also estimated on the basis of physical distances (in Mb) available from the Metric Physical Map (Maps of Human Chromosome 19). The genetic-distance:physicaldistance ratio assumed for chromosome 19p13.1-13.2 (1.9 cM/Mb) is according to Mohrenweiser et al. (1998, fig. 2A ). To calculate the genetic distance of D19S839, its radiation-hybrid distance (in cR 10,000 ) from D19S413 (GeneMap'99) was converted into centimorgans, by use of a ratio of 0.2 Mb/cR 10,000 . Kosambi's function, v p , was applied to
Age Estimation
To yield an appropriate estimate of the age of the mutation, two different algorithms were used, both of which are based on the "genetic clock" equation (Labuda et al. 1997) ,
, relating the time (in genln P p Ϫvg erations [g]) back to the most recent common ancestor of mutant chromosomes, the frequency of recombination between the disease locus and the marker (i.e., v), and the probability that a marker's allele on a disease chromosome is the ancestral one (P). An unbiased estimate of P is the proportion of observed haplotypes that are ancestral. The first method relies on the algorithm of Risch et al. (1995) ,
The second method generates a Markov transition matrix (K), which gives the probabilities that, in a single generation, any one haplotype will be transformed into any other one. K is calculated as the weighted sum of matrices corresponding to recombination (R), mutation (M), and no event occurring (I):
where m is the frequency of mutation at the marker locus. Matrix R has the elements , ,
, and . If a stepwise mutation
model for microsatellites (Goldstein and Pollock 1997) and a distribution of marker allele sizes on disease chromosomes that matches that seen in the control population are assumed, then M has the elements ,
, and , where f is the
frequency of all one-mutant neighbors of the ancestral allele in the control population. With the parameters of K specified (under the assumption of for m p .00056 dinucleotide repeats [Weber and Wong 1993] ), the number of generations g that have passed since the foundation event is estimated by multiplication of the state vector (q, ) by K iteratively until the observed pro-1 Ϫ q portion of ancestral haplotypes is reached ( ). Itq ≈ p D eration begins at a frequency vector of (1,0), corresponding to the archetypal condition of only ancestral haplotype. The number of times that K is multiplied yields the estimate of g .
The setting of the genetic clock according to the approach of Luria and Delbrü ck (1943) , which takes into account the population growth rate, was performed by correction of the estimated age, as follows: Age estimates based on each marker's data have been analyzed by the conventional procedures used for parametric variables, by the SPSS program, version 9 (SPSS). A minimum CI for the age estimates was calculated by (2), with the minimum CI for d (Diaz et al. 2000) .
Statistical Analysis
Statistical analysis was performed by the SPSS program, version 9. Before comparison of subgroups of G197del carriers according to country of residence, PLPs were adjusted for sex and age, by linear multiple-regression analysis. The allele distribution for ApoE and SR-BI polymorphisms was determined by gene counting. The impact of ApoE and SR-BI genotype on PLP of carriers was tested by application of variance-covariance analysis to each plasma-lipid variable, with genotype subgroup as fixed factor, sex as random factor, and age as covariate. The general linear model (multivariate analysis) failed to provide more information. The level of statistical significance was set at . P p .05
Results
LD Analysis and Age Estimation
Genomic DNA samples from 79 index cases with FH (table 1) and from additional family members (when available) were typed for the G197del LDLR mutation and for alleles at three flanking polymorphic markers (D19S221, D19S865, and D19S413), to determine whether patients from unrelated families and different locations harbored the same mutation identical by descent. A putative ancestral three-allele haplotype (D19S221:104-D19S865:208-D19S413:74) was identified in G197del chromosomes from 54 (68%) of the index cases, either as certain (when phase could be unambiguously determined) or as most likely (when genotypes were consistent with the conserved haplotype). As well, five related haplotypes (104-208-70, 104-202-74, 104-210-74, 98-208-74, and 106-208-74) were found in 14 (18%) of the index cases, either as certain or as most likely. Since it is only at one marker that these haplotypes vary from the ancestral 104-208-74 haplotype, it is likely that they derived from the latter by either recombination or mutation.
We analyzed the frequencies of STR alleles associated with G197del and compared them with the corresponding allele frequencies in the background AJ population (table 2) . On G197del chromosomes, alleles at each marker locus were counted only when the marker's haplotype was known for certain (phased chromosomes or locus homozygosity). When data from the certain haplotypes and from the most likely haplotypes were pooled, the resulting allele frequencies proved to be similar to those reported in The presence of detectable LD at markers flanking the LDLR locus, as well as the availability of defined map distances for each of them, allowed the estimation of the coalescence time for G197del chromosomes. To account for the uncertainty inherent in the mapping of tightly linked loci, genetic distances between markers and the LDLR locus were obtained from two sources: directly, from sex-averaged v values (Couture et al. 1999) , and indirectly (via genetic to physical distance ratio), from physical maps publicly available from the Lawrence Livermore National Laboratory Human Genome Center (see its Maps of Human Chromosome 19 website) and GeneMap'99. The two v values were in excellent agreement for D19S865 ( and .026, v p .025 respectively), whereas a significant difference was observed for D19S221 and D19S413 (the difference in v values was .006 and .008, respectively). This minor inconsistency is not uncommon when a comparison is made between genetic distances from different sources (e.g., see Colombo and Carobene 2000; Diaz et al. 2000) .
Age was estimated in two ways. First, we applied the algorithm of Risch et al. (1995) , a method for estimating the coalescent time of mutant chromosomes that focuses on the proportion of lineages not having undergone either a mutation or a recombination event (eq. [5]). The age of the most recent common ancestor (expressed in terms of g) is expressed as a function of v and d, which is a measure of LD (Bengtsson and Thomson 1981) (also known as "P excess " [Lehesjoki et al. 1993] ). Because d is a function of two conditional probabilities-that is, p D and p N -it could be estimated from case-control data obtained from separate samples of independent mutation-bearing and normal chromosomes (table 2). Using a simple general model, Lazzeroni (1998) recently showed how d can be interpreted in terms of identityby-descent probabilities. To take into account the presence of a proportion of nonancestral alleles among the mutation-bearing chromosomes, a second approach was undertaken, which models the regeneration of the ancestral haplotype by the recombination process. This can be done in a number of ways. We chose the Markov transition-matrix method of Reich and Goldstein (1999) , for its flexibility. Under this model, it was straightforward to include both recombination and mutation data for each marker. As suggested by Goldstein et al. (1999) , for simplicity we assumed a strict stepwise mutation model for STRs (Goldstein and Pollock 1997) . Table 4 shows the age of origin of the G197del LDLR mutation, as estimated by the two methods. The age estimate varies considerably from marker to marker. This disappointing feature of the results is probably due both to sampling variation in allele frequencies at different loci and to the uncertainty linked to the calculation of the v values and is common to mutation dating by LD analysis (Guo and Xiong 1997) . The mean ‫ע‬ SD overall age estimate is g (95%CI 11.8 ‫ע‬ 6.4 6.7-16.9 g) according to the Risch et al. (1995) algorithm and is g (95%CI 6.4-16.2 g) according 11.3 ‫ע‬ 6.1 to the Reich and Goldstein (1999) iterative method. Since the age estimate provided by LD analysis at each marker locus is based on two v values, it is questionable whether the six available age estimates are really independent of each other. If we consider the pair of v values as nonindependent variables, then the mean age estimates obtained by the two methods remain unchanged and a small change is observed in their SD, whereas the corresponding 95%CIs increase remarkably (to 4.0-19.6 and 3.6-19.0, respectively).
It is possible that the age estimated by the two methods is an underestimate: attention has been directed, by several previous reports, to the fact that, when applied to growing populations, the genetic clock ticks more slowly than expected (Luria and Delbrü ck 1943; Hä stbacka et al. 1992; Kaplan et al. 1995; Labuda et al. 1996 ). This was originally described for mutations in growing bacterial cultures and can be corrected as proposed by Luria and Delbrü ck (1943) . In human population genetics, this correction was first applied in an LD fine-mapping study that used Finnish-population haplotype data to study the diastrophic dysplasia gene (Hä stbacka et al. 1992) . When genetic distances are available and the unknown parameter is the age of the founder effect, this approach (Labuda et al. 1996; Colombo 2000) sets the genetic clock by introducing a correction factor, g 0 (eq. [4]). Given the v between each marker and the LDLR locus, (2) (Risch et al. 1995) ; g 2 is the age obtained according to the iterative procedure of Reich and Goldstein (1999) , when equation (3) is used; g 1c and g 2c were obtained from equation (4). Iterations stopped at an average distance of from the corresponding p D value.
Ϫ3
‫5ע‬ # 10 g 0 was calculated by use of equation (5) 
Sex averaged, from Couture et al. (1999) . d Estimated on the basis of physical distance (in Mb), by use of the conversion factor 1.9 Mb/cM and Kosambi's map function.
e Estimated by use of radiation-hybrid distance (in cR 10,000 ) of D19S865 from D19S413 (conversion factor 0.2 Mb/cR 10,000 ) and Kosambi's map function.
and under the assumption that is the mean AJ d p .4 population growth rate (Risch et al. 1995; Labuda et al. 1997) , the parameter g 0 was calculated (table 4) by equation (5). The mean ‫ע‬ SD overall estimates corrected for population growth according to the Luria-Delbrü ck approach are g (95%CI 13.6-24.2 g) and 18.9 ‫ע‬ 6.6 g (95%CI 13.3-23.5 g), for the ages cal-18.4 ‫ע‬ 6.4 culated according to the methods of Risch et al. (1995) and Reich and Goldstein (1999) , respectively. However, a common source of uncertainty in the Luria-Delbrü ck correction of the genetic clock is the value of d. To account for the variability of d, we calculated the geometric mean ‫ע‬ SD of the corrected ages estimated with the extreme values of a reasonable range of AJ population growth rate (.1-.8), g (95%CI 14.9-26.3 g) 20.6 ‫ע‬ 7.1 and g (95%CI 14.6-25.6 g), respectively. 20.1 ‫ע‬ 6.9 Thus, according to the results from the two methods used and with consideration of v values (from which the results were obtained) as independent estimates, the age of the most recent common ancestor of G197del chromosomes can be estimated as 20 g (95%CI 15-26 g) .
The minimum CIs for the estimated age can also be calculated with reference to the variance of the LD index, by use of equation (2), with the approximate CI for d being derived from var(d), obtained by equation (1). When the mean v values for each marker are used, the minimum CIs are 9-33 g (for D19S221), 16-37 g (for D19S865), and 7-16 g (for D19S413). The median value for g (corrected for population growth at ) is 21. d p .4 As recently pointed out by Diaz et al. (2000) , it is difficult to calculate a "true" CI for the estimate of g, because, under the assumption of LD, the mutation-bearing chromosomes are not independent (Risch et al. 1995; Rannala and Slatkin 1998) . For convenience, we have been using the term "confidence interval" (here denoted as "CI"), but it is important to appreciate that these calculations are meant to be illustrative of how an estimated demographic parameter (i.e., d) influences confidence and that they cannot be construed as producing the formal CI. Assumptions concerning the population growth rate strongly influence the degree of mutation-bearing chromosomes' nonindependence and, hence, the CI. Rapid demographic expansion soon after the mutational event (or a bottleneck) leads to greater statistical independence and narrower CIs, whereas a flat demographic curve leads to less independence and broader CIs (Rannala and Slatkin 1998; Goldstein et al. 1999) . Thus, the minimum CIs for g calculated by means of the var(d) are not independent of the CI obtained with the extreme values of a reasonable CI for AJ population growth rate, and it is not evident which of the two CIs reflects more reliably the "true" CI. Further investigations will be necessary to refine an appropriate algorithm to solve the CI problem; however, it is questionable whether its implementation will be either easy or of great benefit (Diaz et al. 2000) .
Genotype and Biochemical Phenotype
Despite remarkable changes in climate and diet, no significative difference in PLP, adjusted for sex and age, was observed among index cases clustered according to the three main countries of residence (Israel, South Africa, and Russia) (table 1). [Tsuda et al. 1994 ];
, 0.62, and 1.36, n p 86 p p 0.14 respectively, corrected according to the method of Bonferroni).
ApoE polymorphism is known to influence PLP (Hagberg et al. 2000) . In our sample of patients with FH, no statistically significant effect of ApoE genotype on PLP was observed (table 5) . However, in e4 carriers, baseline TC ( mg/dl) and HDL-C ( mg/dl) are 345 ‫ע‬ 81 38 ‫ע‬ 8 appreciably lower than those in noncarriers (380 ‫ע‬ 90 and mg/dl, respectively), and this unexpected 45 ‫ע‬ 13 result, although devoid of statistical significance (the sample of e4 carriers and noncarriers is small), nonetheless suggests that the reported hyperlipidemic effect of e4 in normal subjects does not apply also to patients with FH who have G197del. Sex was a statistically significant factor in the determination of HDL-C levels, with females exhibiting a constantly higher profile ( ). As has been reported elsewhere (Leitersdorf P p .012 et al. 1991) , in G197del heterozygotes age is a significant predictor of TG plasma level, with the elderly having a level higher than that in younger individuals (P p ). A mild age-dependent increase in TC, HDL-C, .017 and LDL-C was observed also.
There is evidence that SR-BI may affect LDL-C and HDL-C metabolism (Acton et al. 1999) . However, in our sample of patients with FH, in no instance did SR-BI genotype play a statistically significant role in the determination of PLP (table 6) . Again, sex was associated with a borderline statistical significance (P p ) in the determination of HDL-C, with females ex-.049 hibiting a constantly higher level except in the subgroup of patients who are homozygous for the common (i.e., wild-type) allele C.
Discussion
A highly conserved 104-208-74 haplotype-as well as five closely related haplotypes, which vary from the former at one marker only-were identified in 86% of G197del-bearing chromosomes of 79 unrelated families with FH who were from five countries. This finding suggests that most, if not all, G197del chromosomes derive from a single ancestral chromosome on which the mutation arose in a 104-208-74 background.
The presence of G197del chromosomes with haplotypes differing from the conserved one at more than one locus (14% of the families with FH who have G197del) could be explained either by greater decay of the ancestral haplotype in some descent or by recurrent G197del mutation on different haplotypes. The former possibility would imply that the founder mutation had existed earlier in the non-AJ populations and subsequently was introduced, by two or more independent G197del chromosomes, into the AJ population, in which it spread. Although rare, the case of a recurrent 3-bp deletion cannot be excluded. Recently, Klein et al. (1998) reported two identical de novo GAG deletions in the DYT1 gene; the same mutation has arisen a limited number of times throughout the centuries (Valente et al. 1999) . However, the discovery that G197del occurs at a high frequency in patients with FH who are of Lithuanian Jewish origin (Meiner et al. 1991) suggests that this mutation may have originated (or been introduced by gene flow) and subjected to earlier expansion in Lithuanian Jewry. To provide further evidence for the hypothesis of a "Lithuanian mutation," we compared the apparent age of G197del versus the historical and demographic data on eastern-European Jews.
Two different methods of age estimation were used, both of which are based on quantitative analysis of haplotype data for LD decay over time. The first algorithm (Risch et al. 1995) , which neglects the contri- bution of STR mutation rate to the decay of LD, requires three parameters-p D , p N , and v-that are potential sources of errors due to either sampling bias (in the case of p D and p N ) or uncertainty in the estimate (in the case of v). Significance of LD with respect to observed p D and p N was then assessed by estimation of the difference in allele proportions for each marker (corrected ). A critical factor in LD methods for P ! .0001 dating the age of mutations is the confidence in the v between the disease locus and the marker: the resulting value for g is very sensitive to fluctuations in v. Since, because of the short (4 cM) genomic interval, the crossover-based genetic distances between the enlisted markers and the LDLR locus (Couture et al. 1999 ) are based on a limited number of observed recombinations, v values were also conveniently derived from physical distances. However, this approach suffers from a source of uncertainty too. The genetic-distance:physical-distance ratio is not uniform along the chromosomes, and an average conversion factor from megabases (or cR) to centimorgans underestimates physical distances close to the centromeres and overestimates them in telomeric regions (Watkins et al. 1994) . Even within each region there are remarkable differences between cytogenetic bands, which could be responsible for gross errors in the estimation of v. In our case, the study by Mohrenweiser et al. (1998) , which is based on the incorporation of 180 genetic markers into the metric physical map of human chromosome 19, provided a reliable tool for inference of a definite conversion factor (1.9 cM/Mb) for 19p13.1-p13.2. In addition to the three parameters discussed above, the Markov transition-matrix method requires an STR mutation-rate estimate that is not free from uncertainty. In our study, we assumed the m value given by Weber and Wong (1993) for dinucleotide repeats (i.e., ).
Ϫ4
5.6 # 10 An order-of-magnitude increase in STR mutation rate (which is probably the case for D19S965) does not substantially change the overall three-marker estimate of g.
The age estimates resulting from the application of the two algorithms, which are different ways of solving the same dynamic system, agree remarkably with each other. This is consistent with the fact that, in our case, v values are two orders of magnitude higher than the average frequency of mutation at marker loci; thus, the contribution that mutation makes to the breaking of LD over time is comparatively very small. For d p .4 (Risch et al. 1995; Labuda et al. 1997) , the Luria-Delbrü ck correction of the genetic clock yields ages that are 6-8 g older than the uncorrected estimations. However, because of the uncertainty with regard to the AJ population growth rate (d varies from century to century and from settlement to settlement), we preferred to rely on the mean (i.e., 20 g) of the corrected ages estimated by use of d interval (.1-.8) that reflects conservatively the available demographic data. Although the expected coalescence time is independent of the shape of the genealogy, CIs are strongly dependent on the precise shape . Growing populations produce star genealogies, which are not the same as those assumed in the Luria-Delbrü ck correction, which have regular internode lengths (as pointed out by one of the anonymous reviewers of the present article). However, even if we account for this source of uncertainty, it is striking that the CI for the coalescence time still includes the approximate time of foundation of the ancestral Lithuanian Jewish community (see below).
If it is assumed that years (Tremblay and Vé-g p 30 zina 2000; Sigurgardottir et al. 2000) and that 1960 is the average year of birth of the subjects enlisted in the present study (table 1) , the present results would date the most recent common ancestor bearing G197del back to 1360 A.D. (95%CI 1180 A.D. (95%CI -1510 , where the CI for the three-markers-based mean estimate relies on the range of AJ population growth rate assumed for the Luria-Delbrü ck correction. Alternatively, the same coalescence analysis would date back to 1330 A.D. if a median value (i.e., 21 g) for the corrected age is calculated by use of the minimum CIs derived from the variance of LD index (see the Results section Several disease mutations present in AJ individuals can be traced back to medieval progenitor Jewish populations; these mutations include Bloom syndrome (MIM 210900) blm(Ash), mutations associated with factor XI deficiency (MIM 264900) type II, Gaucher disease (MIM 230800) N370S and 84GG, adenomatous polyposis of the colon (APC [MIM 175100]) I1307K, mutations associated with familial dysautonomia (MIM 223900), the idiopathic torsion dystonia (MIM 128100) DYT1 GAG deletion, and breast-ovarian cancer (MIM 113705) BRCA1 185delAG mutations. LD analyses have suggested that chromosomes bearing some of these mutations identically by descent coalesced in the AJ population around or before the 11th century (Colombo 2000, table 2; Diaz et al. 2000) . This is consistent with major AJ bottlenecks occurring during the second half of the first millennium and the beginning of the second one, when the population became established in Europe. Our mutation-dating results suggest that the most recent common ancestor of G197del chromosomes belongs to the first half of the second millennium-that is, the late Middle Ages-when new opportunities for a founder effect were offered by Jewish settlers moving eastward. Despite the methodological limits associated with LD-based age estimation, the present results, taken together with the ancestral Lithuanian AJ origin of most G197del chromosomes, are consistent with the following historically plausible scenario for the origin and spread of the mutation. It is well known that, before the 16th century, AJ individuals preferred to reside in small urban communities (Motulsky 1979) . Early migrations of AJ individuals from medieval Germany eastward could have been encouraged by new opportunities related to the rise of towns in the developing new states (Davies 1984) . Furthermore, in western Europe the life conditions for Jews soon became unfavorable: persecutions increased during the time of the Crusades and intensified on the occasion of the outburst of bubonic plague (14th century), resulting in the decimation of the Jewish communities. Privileges were granted to Jews in eastern countries-for example, in Kalisz (1264), Cracow (1334), Lesser Poland and Red Russia (1364), and Lithuania (1338). The foundation of the ancestral Jewish community of Lithuania occurred in 1338 A.D. (Ankori 1979) . During the 14th century, the G197del LDLR mutation could have been introduced into the chromosomes of the first Lithuanian AJ settlers by either a mutational event or gene flow. The favorable circumstances, which led to the great demographic expansion of AJ individuals in this part of Europe (Davies 1984; Barnavi 1992; Beirnart 1992) , were presumably promoted by the establishment of the Jagiellonian commonwealth (Poland, Lithuania, Ukraine, and Belarus) toward the end of the 14th century. The total number of Jews living in Poland and Lithuania around 1500 A.D. is estimated to have been 10,000-12,000 (Weinryb 1972) . Such a rapid population growth from a limited number of settlers would have established a founder effect. When Lithuania was conquered by Russian troops during the 17th century, Lithuanian AJ individuals became inhabitants of Russia. It is known that during the following centuries practically all of St. Petersburg's Jews came from the western territories of the former Russian Empire settled by AJ individuals from Lithuania and Poland (Bershadskyi 1893) . Lithuanian Jews lived in a relative cultural and environmental isolation until the turn of the 19th century, when many of them emigrated to South Africa, Great Britain, Australia, America, and Palestine (Gar 1971) . The presence of G197del in six unrelated Jewish families with FH who live in England (Gudnason et al. 1993 ) could be explained by the fact that Great Britain assisted emigration of Jews from Tsarist Russia. Since ∼40,000 Lithuanian immigrants came to South Africa during 1880-1910 and gave rise to most of the local AJ population, it is not surprising that G197del was found in 8 of 10 FH cases in the local Jewish community (Meiner et al. 1991) . The same argument applies to Israel, where hundreds of thousands of Jews from eastern Europe settled after the World War II, thus introducing G197del by gene flow from multiple independent families with FH. Therefore, the estimated age of the G197del LDLR mutation, the origin and geographic distribution of families with FH, and the history of eastern-European AJ individuals are consistent with the hypothesis that the mutation originated (or was originally introduced) and has been subjected to earlier expansion in Lithuania.
The high frequencies of certain single-locus genetic diseases in the AJ population has long been a subject of interest (Goodman and Motulsky 1979) . However, the underlying genetic mechanism(s) accounting for their elevated prevalence remains controversial. Some authors have attributed this epidemiological figure to the demographic upheavals thought to have occurred during or shortly after the 16th and 17th centuries: the founder effect resulted from the AJ population's extraordinary growth after a fortuitous introduction of disease alleles into a relatively small group of individuals from whom present-day the AJ individuals have descended (Risch et al. 1995) . Other investigators have suggested that a heterozygote selective advantage has been the operative genetic mechanism (Myrianthopoulos et al. 1972; Petersen et al. 1983; Diamond 1994; Zoossmann-Diskin 1995) . For Tay-Sachs (MIM 272800) and other recessive lysosomal storage disorders, it has been speculated that heterozygotes may have an increased resistance to some infectious diseases-for example, tuberculosis. Although this suggestion is attractive and although some geographic distributions of allele frequencies appear to support, in part, the argument of positive selection, a clear biological benefit of heterozygosity for these (Jorde 1992 ) and other (Hö -genauer et al. 2000) mutations is difficult to document. Genetic drift in a population ancestral to AJ individuals remains a third possibility , and the recent finding that a common N370S allele, causing Gaucher disease type 1, is concurrently present in the AJ population and in the neighboring non-Jewish Eu-ropean populations allows some inferences to be drawn (Diaz et al. 2000) .
For diseases in the AJ population, the study of the origin and spread of an autosomal dominant mutation offers an advantage over the investigation of recessive disorders such as Tay-Sachs disease or Gaucher disease. The distinct opportunity derives from the consideration that heterozygote selective advantage does not operate in this case: dominant pathological mutations are subject to direct selection over disease phenotype. This opportunity has been exploited already by Risch et al. (1995) , who studied the DYT AJ mutation causing idiopathic torsion dystonia in AJ individuals. Unfortunately, the DYT AJ model is complicated by the highly variable expression of the gene, since only a small proportion of carriers manifest a severe form of the disease. If both mild and severe cases are included, the overall penetrance is ∼30% (Bressman et al. 1989; Risch et al. 1990 ). According to Risch et al. (1995, p. 156) , "perhaps only a third of those with clinical symptoms would be categorized as severely affected," and only "severely affected individuals tend not to reproduce." Other autosomal dominant AJ diseases-for example, BRCA1, BRCA2, and APC-show reduced penetrance as well.
The G197del LDLR mutation causes clinically manifested FH both in heteroallelic status and in homoallelic status (although the latter is rare-our Piscataway index case is the only patient described so far), and its biochemical phenotype is easily quantifiable. Ninety-four percent of the heterozygotes ( ) in our G197del-n p 98 FH register (i.e., index cases and their G197del-positive family members) were hypercholesterolemic (LDL-C 1160 mg/dl), and there is no significant difference in the mean PLP of patients with FH who have G197del and are from the three main countries of residence (Israel, South Africa, and Russia), whose geographic characteristics, dietary habits, and lifestyles are remarkably different. These findings are consistent with a disease mutation with both a high degree of penetrance and independence of major environmental effects. This is not always the case for LDLR mutations causing FH (Moorjani et al. 1993; Bertolini et al. 2000) . We have no clear-cut explanation of the discrepancy between our results and those of the study by Pimstone et al. (1998) , who compared PLPs in Chinese subjects with FH and defined LDLR mutations who were living in China and Canada. Higher LDL-C levels, apparently not linked to a different functional class of LDLR mutations, were observed in FH heterozygotes residing in Canada than were seen in FH heterozygotes living in China. These differences were ascribed, at least in part, to the striking contrast, both in dietary lipids and in physical-exercise level, between the two groups of patients.
The frequency distribution of ApoE alleles e2-e4 in our sample of G197del carriers was similar to that found in the general AJ population (Tsuda et al. 1994) . This observation confirms the lack of difference in ApoE allele distribution among patients with FH from Europe and North America who have been reported elsewhere (O'Malley and Illingworth 1990; De Knijff et al. 1990; Dallongeville et al. 1991; Carmena-Ramó n et al. 2000) . By contrast, Eto et al. (1988) described a higher frequency of e4 in Japanese patients with FH, which may reflect specific genetic differences between Asian and white population samples with FH. The lack of association between ApoE polymorphism and G197del is consistent both with the genetic distance between ApoE and the LDLR locus (45 cM) and with the hypothesis that the founder mutation arose on the most common haplotype (i.e., e3) in the AJ population. The effect of ApoE genotype on basal plasma-lipid levels has been studied in different populations. In some studies of subjects without FH, e4 carriers showed the highest plasma TC and LDL-C levels, whereas lowest levels were found in e2 carriers (reviewed in Hagberg et al. 2000) . Our results suggest that ApoE polymorphism does not significantly contribute to variations in plasma baseline TC or LDL-C in patients who are heterozygous for G197del. The lack of statistical significance is likely due to the small sample of ApoE subgroups. Our finding is in contrast with those of Eto et al. (1988) in Japan, Ward et al. (1996) in northern Ireland, and Bertolini et al. (2000) in Italy, who found, among e4 carriers, significantly higher plasma levels in individuals who are heterozygous for FH, but it is consistent with those of Carmena-Ramó n et al. (2000) in Spain and other investigators in Europe and North America, including a study of 112 unrelated French Canadian FH heterozygotes with a class I (null allele) 10-kb deletion in the LDLR 5 region (Bétard et al. 1996) . Taken together with the absence of evidence for significant countrydependent difference in FH baseline PLPs (our data) and the observation that, in contrast to subjects without FH, in patients with FH the individual response to changes in dietary lipids is not affected by their ApoE genotype (Carmena-Ramó n et al. 2000) , the results of the present study are consistent with the hypothesis that the impact of severe mutations at the LDLR locus could prevail over genetic factors and genetically modified response to environmental changes. This is true also for the SR-BI polymorphism, which does not appear to modify plasma LDL-C levels in our sample of patients with FH. The present study cannot be considered in any sense a systematic screen for genetic modifiers of the biochemical effect of G197del; further investigations should shed light on whether the "right modifiers" exist. We may therefore conclude that both the environmental factors and the candidate modifying genes analyzed in the present study do not affect to a significant extent the phenotypic expression of G197del FH, which appears to be a severe, highly penetrant inherited disease in AJ individuals. Nevertheless, we cannot exclude the possibility that the G197del LDLR mutation and other common mutations in AJ individuals may be endowed with some selective advantage that is not linked to known functions of the expressed proteins; however, so far, this remains, in practice, an unverifiable speculation.
Taken as a whole, the evidence presented in this and other studies suggests that heterozygote advantage is not essential for a mutation to cause elevated disease incidence among contemporary AJ individuals. The evidence also strengthens the importance of consideration of the founder effect in a population rapidly expanding from a limited number of families, as a simple, parsimonious hypothesis to explain the spread of recent mutations in the AJ population. However, the role of positive selection due to some heterozygote advantages or genetic factors modifying the response of a mutation's carriers to historical or local environmental constraints cannot be generally dismissed without proof.
